I was looking at insider ownership and it looks like they just about sold all their shares. The institutional ownership in this stock is very large. There's quite a few institutions that own their shares at $11.31. I wander whose company, the analysts represents, to write articals pricing the stock so high.
It isn"t hard to see that the stock is being manipulated. There is just not enough buyers out there to support the number of shares these institution need to sell without losing a lot of money. Every time they go to sell, it drops alot on minimum shares. Just look at AH, .83 on 10,000 shares.
I am not one to short a stock, but I can"t find a single reason to be long on this stock. If the drug is no different then the placebo, then how would it have any kind of safety issues or not be efficient? Wait, maybe we should be asking the roughly 16% that didn't finish the testing.
it is also interesting that you are obviously short...That is fine, just say so, but please do not insult the intelligence of us that can spot your type from miles away with your "questions"...and spell check would not hurt either!
I am more interested in the direction of this stock, then I am about spelling. If I am short and wrong, then it would be wise to cover my short interest and go long. I had to short the stock. I am willing to lose my nice little profit shorting twitter, in order to prove myself right, that this stock shouldn't have a 1.4 billion dollar market cap (maybe $400 million). Unless I can find something (other then the safety and effectiveness of a failed 50mg drug) that made this stock pop $10, shorting it only makes since.